Early recognition of anti-N-methyl D-aspartate (NMDA) receptor encephalitis presenting as acute psychosis

Australasian Psychiatry

Volumn 21, Issue 6, 2013, Pages 596-599

  Tidswell, Jessica ^a   Kleinig, Timothy ^a,b   Ash, David ^b,c   Thompson, Philip ^b   Galletly, Cherrie ^b,d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Central Adelaide Local Health Network   (Australia)

^d Ramsay Health Care   (Australia)

Author keywords

Anti N methyl D aspartate receptor encephalitis; First episode psychosis

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; NEUROLEPTIC AGENT; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY;

ACUTE PSYCHOSIS; AGITATION; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; CANCER SURGERY; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISORIENTATION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE UNIT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TERATOMA; PARANEOPLASTIC NEUROPATHY; PARANOIA; PATHOPHYSIOLOGY; PLASMAPHERESIS; SCHIZOPHRENIA; SCREENING; ULTRASOUND;

ANTI-N-METHYL D-ASPARTATE RECEPTOR ENCEPHALITIS; FIRST EPISODE PSYCHOSIS;

ADULT; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; FEMALE; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84889059882     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1177/1039856213506502     Document Type: Article

References (16)

1. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127: 701-712.
2. Finelli PF. Autoimmune limbic encephalitis with GAD antibodies. Neurohospitalist 2011; 1: 178-181
3. Vitaliani A, Buckley C, Schott JM, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratome. Ann Neurol 2005; 58: 594-604.
4. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63-74.
5. Peery H, Day G, Dunn S, et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunology. Autoimmunity Reviews; 11: 863-72
6. Finke C, Kopp U, Pruss H, et al. Cognitive deficits following anti-NMDA receptor encephalitis.J Neurol Neurosurg Psychiatry 2012; 83: 195-198.
7. Titulaer M, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for longterm outcome in patients with anti-NMDA encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-165.
8. Iran SR, Bera K, Waters P, et al. N-Methyl-D-asparate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133: 1655-1667.
9. Gable M, Sheriff H, Dalmau J, et al. The frequency of autoimmune n-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the california encephalitis project. Clin Infect Dis 2012; 54: 899-904.
10. Kleinig T, Thompson P, Mata W, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008; 23: 1256-1261.
11. Hughes E, Peng X, Gleichman A, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30: 5866-5875.
12. Coyle J. (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell MolNeurobiol 26: 365-378
13. Zandi M, Irani S, Lang B, et al. Disease relevant autoantibodies in first episode schizophrenia. J Neurol 2011; 258: 686-688.
14. Wilson B, Prain K, Gillies D, et al. Laboratory testing for anti-NMDAR in autoimmune encephalitis: the HSSA - Pathology Queensland Experience. Topical Update- The Hong Kong College of Pathologists 2013; 8: 1-8.
15. Dalmau J. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.Ann Neurol 2008; 65: 424-34.
16. Lai M, Hughes EG, Peng X, et al. Glutaminergic (N-methyl-aspartate receptor) hypofrontality in schizophrenia: Too little juice or a miswired brain? Mol Pharmacol 2009; 77: 317-325.